My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
October 2010
Patient Care and Science
ACIP Targets Pertussis Vaccination Gaps
Committee Also Recommends Booster Meningitis Vaccine Dose For Teens

In light of the recent pertussis outbreak in California and other parts of the country, the federal Advisory Committee on Immunization Practices (ACIP) at its October meeting recommended steps to fill in some vaccination gaps. The committee recommended a single dose of the tetanus, diphtheria, and pertussis (Tdap) vaccine for adults 65 years of age and older who have close contact with infants less than one year old. In addition, those 65 and older who have not received the tetanus-diphtheria (Td) vaccine should receive a single dose of the Tdap vaccine in its place.

The committee also recommended that teenagers receive a booster dose of the meningococcal conjugate vaccine. The recommendation follows studies suggesting that antibodies generated by the vaccine decline rapidly and may no longer be protective five years after vaccination, according to IDSA’s ACIP liaison, Samuel Katz, MD, FIDSA.

Children who have received the vaccine according to the existing recommendation, at 11 to 12 years old, should now receive a booster dose at age 16. Those who may have been vaccinated at ages 13 to 15 should receive a booster dose five years after that (i.e., at 18 to 21 years old).

ACIP recommendations become official once approved by the Centers for Disease Control and Prevention (CDC) and published in MMWR.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
EIN Update: Multidrug-Resistant Gram-Negative Infections
NIAID Funds Four Antimicrobial Resistance Clinical Trials
ACIP Targets Pertussis Vaccination Gaps
“Get Smart” Week Urges Appropriate Antibiotic Use
IDSA Resources for Mobile Devices Now Available for iPad
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Physician Payment Cuts Again Looming
Medicare Internet Enrollment Deadline is Jan. 3, 2011
E&M Service Codes Face Higher Scrutiny, Some Claims Delayed
Global ID
Pakistan Flood Response Resources
Hearing Rebuts Myths about PEPFAR’s Impact
Science Speaks, the Center’s Blog, Has New Home
Policy and Advocacy
House Lawmakers Introduce Bill to Spur Antibiotic Development
ID Experts Outline Framework to Eliminate HAIs
Your Colleagues
New IDSA, HIVMA Board Members Take Office in Vancouver
Congratulations to the 2010 Society Award Winners!
Members on the Move
Welcome, New Members!
Education & Resources
How to Claim CME/CPE Credit from the IDSA Annual Meeting
Online Infection Control Course Recently Updated
Invasive Mycoses Online CME Activity Available
Top Stories
NIAID Director Highlights Need for Preparedness Against ID Threats
Even With Budget Constraints, U.S. Response to Global HIV/AIDS Is Powerful
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.